High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts

European Journal of Immunology

Volumn 31, Issue 10, 2001, Pages 2936-2941

  Yamamoto, Toshiyuki ^a,b   Eckes, Beate ^a   Krieg, Thomas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Fibroblast; Monocyte chemoattractant protein 1; Systemic sclerosis

Indexed keywords

COLLAGEN; DACTINOMYCIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CELL TYPE; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMIS; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; FIBROSIS; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SCLERODERMA; SKIN; SKIN FIBROBLAST; STAGING; SYSTEMIC SCLEROSIS;

CELLS, CULTURED; CHEMOKINE CCL2; FIBROBLASTS; HUMANS; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; UP-REGULATION;

EID: 0034777651     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(2001010)31:10<2936::AID-IMMU2936>3.0.CO;2-0     Document Type: Article

References (35)

1. Systemic scleroderma. Clinical and pathophysiological aspects
2. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
3. Fibroblast selection in scleroderma. An alternative model of fibrosis
4. Collagen synthesis by scleroderma fibroblasts
5. Control of fibrosis in systemic scleroderma
6. Cytokines and systemic sclerosis
7. Connective tissue metabolism including cytokine in scleroderma
8. Cellular infiltrates in scleroderma skin
9. Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization
10. Fibrogenic cytokines and connective tissue production
11. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor the answer?
12. Transforming growth factor β (TGF β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts
13. Transforming growth factor-β increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts
14. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
15. Transforming growth factor type β: Rapid induction of fibroblasts and angiogenesis in vivo and stimulation of collagen formation in vitro
16. Colocalization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis
17. Evaluation of transforming growth factor β and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization
18. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: A mediator of fibrosis?
19. Human monocyte chemoattractant protein-1 (MCP-1)
20. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties
21. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis
22. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescent nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis
23. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis
24. Costimulation of fibroblast collagen and transforming growth factor β 1 gene expression by monocyte chemoattractant protein-1 via specific receptors
25. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 α loop
26. Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional response to interleukin 1 β
27. IL-1 α gene expression and protein production by fibroblast from patients with systemic sclerosis
28. Endogenous IL-1 α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A
29. Monocyte chemotactic and activating factor (MCAF/MCP-1) has an autoinductive effect in monocytes, a process regulated by IL-10
30. Transforming growth factor β 1 positively regulates its own expression in normal and transformed cells
31. Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: Insensitivity to TGF-β 1 stimulation
32. Augmentation of production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1 α (MIP-1 α) and MIP-1 β) in patients with systemic sclerosis: MCP-1 and MIP-1 α may be involved in of pulmonary fibrosis
33. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
34. Synthesis of collagen by human fibroblasts and their SV40 transformation
35. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family